---
title: "ABACHEM signs supply strategic agreement with HENGRUI PHARMA"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251148730.md"
description: "According to the Zhitong Finance APP, ABACHEM announced that the company has signed a \"Supply Strategic Agreement\" with HENGRUI PHARMA. The two parties have reached a framework agreement to establish a forward-looking strategic partnership aimed at jointly promoting technological innovation and quality upgrades of specific pharmaceutical intermediates and active pharmaceutical ingredients (API), enhancing the collaborative competitiveness of key links in the pharmaceutical industry chain, and achieving a win-win value in the field of advanced pharmaceutical manufacturing. This agreement will be effective for the long term, valid until July 31, 2035"
datetime: "2025-08-01T09:07:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251148730.md)
  - [en](https://longbridge.com/en/news/251148730.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251148730.md)
generator: "portal-rs"
---

# ABACHEM signs supply strategic agreement with HENGRUI PHARMA

According to the Zhitong Finance APP, ABACHEM (300261.SZ) announced that the company has signed a "Supply Strategic Agreement" with HENGRUI PHARMA. The two parties have reached a framework agreement to establish a forward-looking strategic partnership aimed at jointly promoting technological innovation and quality upgrades of specific pharmaceutical intermediates and active pharmaceutical ingredients (API), strengthening the collaborative competitiveness of key links in the pharmaceutical industry chain, and achieving a win-win value in the field of advanced pharmaceutical manufacturing. This agreement will be effective for the long term, valid until July 31, 2035

### Related Stocks

- [300261.CN](https://longbridge.com/en/quote/300261.CN.md)
- [01276.HK](https://longbridge.com/en/quote/01276.HK.md)

## Related News & Research

- [2 GLP-1 Stocks That Could Double Your Money by 2031](https://longbridge.com/en/news/296030914.md)
- [Hengrui Pharma launches RMB 1 billion-RMB 2 billion A-share buyback, caps price at RMB 81.78](https://longbridge.com/en/news/296368941.md)
- [Yip’s Chemical FY26 H1 profit attributable to owners more than doubles to HK$141.12 million; revenue rises 17.1% to HK$1.67 billion](https://longbridge.com/en/news/296467317.md)
- [Newtrend signs RMB 65.8 million Jingzhou glycine base construction contract](https://longbridge.com/en/news/296632347.md)
- ["July Was A Bad Month": Jane Street Lost $15 Billion In First Down Month In A Decade](https://longbridge.com/en/news/296131995.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**